Treatment of hyperprolactinemia: a systematic review and meta-analysis. - Wikidata - awgldk - TriplyDB

Treatment of hyperprolactinemia: a systematic review and meta-analysis.

Treatment of hyperprolactinemia: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q36355322

about

Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history Managing Prolactinomas during Pregnancy Cabergoline, dopamine D2 receptor agonist, prevents neuronal cell death under oxidative stress via reducing excitotoxicity Management of macroprolactinomas.Characteristics of dynamic magnetic resonance image enhancement in prolactinomas resistant to dopamine agonist therapy.Hyperprolactinemia and Hirsutism in Patients Without Polycystic Ovary Syndrome Current treatment options for hyperprolactinemia.Surgical treatment of microprolactinomas: pros.Giant prolactinomas: are they really different from ordinary macroprolactinomas?The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia.Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients.Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis.Hyperprolactinaemia in male infertility: Clinical case scenarios.The Chance of Permanent Cure for Micro- and Macroprolactinomas, Medication or Surgery? A Systematic Review and Meta-Analysis

P2860

Q26471022-D6D26559-6EEB-4BFD-A6A2-DB67A02B9A92 Q28080990-6AFBFDFB-D882-4843-BF34-9FEBD03C72FF Q28539553-07B4D6E5-ADFF-4425-8738-38BA6C96E56F Q33792371-BB99388C-D028-4A62-8997-8BD8424D6F86 Q35106933-35D5DBAF-A24F-466B-9067-0B7D2FFA08A6 Q37224505-84721799-BC03-4AF4-BF49-F50C4D896F61 Q38112205-AEB64F3E-A445-48D0-BE12-D3716A879A60 Q38211820-499BF690-1D16-4012-9BDB-E3880C37BC25 Q40329835-10686377-B2B8-445F-848F-96C8A416A04E Q41610640-CE10B4A4-659D-4657-ABC3-4D8693C567EB Q44898008-64C60786-779F-4A9F-B316-BDBE68E969A0 Q47425359-3E0A169D-BCAA-438D-A752-25059252D2A7 Q55093059-9C122ED3-7F09-4CE4-98CB-BE5E7188FD15 Q58556107-D920008A-BAD0-4C66-AE31-40FFC6810AD8

P2860

Treatment of hyperprolactinemia: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q36355322

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Treatment of hyperprolactinemia: a systematic review and meta-analysis.

@ast

Treatment of hyperprolactinemia: a systematic review and meta-analysis.

@en

type

label

Treatment of hyperprolactinemia: a systematic review and meta-analysis.

@ast

Treatment of hyperprolactinemia: a systematic review and meta-analysis.

@en

prefLabel

Treatment of hyperprolactinemia: a systematic review and meta-analysis.

@ast

Treatment of hyperprolactinemia: a systematic review and meta-analysis.

@en

P1433

Q36355322-B801FED8-E3D4-4BF9-A4D0-5CFF00933135

P1476

Q36355322-43955FED-CCF4-4668-BB93-90DDFF670BFA

P2093

Q36355322-1BC28D04-3662-4B70-B637-19643B3A2C5F

Q36355322-1E49B847-EB0A-4A03-B02D-A908D8842679

Q36355322-2D35E430-AF21-4E88-A93E-DA8FF8AED283

Q36355322-40838EB3-0874-44CE-812F-FC1C6A719523

Q36355322-40D792E5-5A6D-46BA-BCAE-A58330E4701D

Q36355322-42927DA5-B284-4DE3-A27C-545474774300

Q36355322-5B12BB4C-125A-459B-8A40-0E8B8422D7AC

Q36355322-87CCD5D6-374B-400C-B1F1-7CA913814D14

Q36355322-CA5476D8-A0B6-43DF-8F0A-554C351A9B28

Q36355322-D16B6D77-2828-4344-96B7-094B764FBF07

P275

Q36355322-9B9F752D-329D-4F52-8901-BA2BCC18F9A1

P2860

Q36355322-00FDE2DB-4A73-4DEA-A01A-2F905E172A6A

Q36355322-01D666B4-E58F-4EFD-B5FA-20A235DF651A

Q36355322-034C66E4-9558-4192-92E4-D93771ED2A91

Q36355322-049CEEDC-6C04-4F40-A812-596BBD13AA41

Q36355322-05FB3665-0844-4D6E-8B17-77848A34CE37

Q36355322-061C6975-AD0E-4237-9FD1-A2114075C3E2

Q36355322-089A51E4-7F91-47D3-AB98-CA55C201279D

Q36355322-0955F73B-3AE2-42DA-99BF-D3CFC0DC28DC

Q36355322-0987766D-8BC2-440B-A767-E84E6C19B9C8

Q36355322-0D2A859B-D57A-4474-A12B-FF17F0AB8DF3

P304

Q36355322-B0CAD1BC-2616-4392-BC73-C7D437FB9EE7

P31

Q36355322-098FCDA9-C59A-442B-8BD5-5AFCF62E7280

Q36355322-198bfbc4-382d-4640-96f3-cb763c52c9a0

P356

Q36355322-B99DD09A-13ED-4D4A-A289-15F476F00B9B

P478

Q36355322-D63EFB74-F967-4245-9FE7-2E6867AAB855

P50

Q36355322-A0CE1CA2-E708-4CBA-AE3D-7E630D145854

Q36355322-AAFD45BC-2103-4E9C-8A56-7BB7CA644DC0

Q36355322-FD415CF5-32FB-4A2B-A599-044561EA7699

P5008

Q36355322-E28BD1EB-DCF4-42BB-88AD-F32EE083C4EB

P577

Q36355322-17A1B782-1F72-4482-AD5B-2F7E5F9CCA9C

P5875

Q36355322-736B9126-9B55-4CB9-85B8-636095B04E0C

P698

Q36355322-4FCC06BE-3E36-4928-88CE-7D6D21A4C74B

P921

Q36355322-99D1EA2B-FE7D-4542-A56D-E210CDD3B6A8

P932

Q36355322-78AB4494-030D-465F-B9D0-3CBAB00FC6E2

P356

P1433

Systematic Reviews

P1476

Treatment of hyperprolactinemia: a systematic review and meta-analysis

@en

P2093

Ahmad Hazem

http://www.w3.org/2001/XMLSchema#string

Amy Bagatto

http://www.w3.org/2001/XMLSchema#string

Amy T Wang

http://www.w3.org/2001/XMLSchema#string

Chaithra Prasad

http://www.w3.org/2001/XMLSchema#string

Fernando Coto-Yglesias

http://www.w3.org/2001/XMLSchema#string

Gunjan Y Gandhi

http://www.w3.org/2001/XMLSchema#string

Jantey Carey

http://www.w3.org/2001/XMLSchema#string

Melanie A Lane

http://www.w3.org/2001/XMLSchema#string

Nicola W Gathaiya

http://www.w3.org/2001/XMLSchema#string

Patricia J Erwin

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

When are randomised trials unnecessary? Picking signal from noise

Measuring inconsistency in meta-analyses

Meta-analysis in clinical trials

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Gene expression profiling of testosterone and estradiol-17 beta-induced prostatic dysplasia in Noble rats and response to the antiestrogen ICI 182,780

Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.

Gamma knife radiosurgery for medically and surgically refractory prolactinomas.

Treatment of prolactin-secreting pituitary macroadenomas with the long-acting non-ergot dopamine agonist CV 205-502.

Long-term follow-up of 246 hyperprolactinemic patients.

Hyperprolactinaemia in males: a heterogeneous disorder.

P304

33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2046-4053-1-33

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Mohammad H. Murad

M Fernandez-Balsells

Victor M. Montori

P5008

P577

2012-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230564521

http://www.w3.org/2001/XMLSchema#string

P698

22828169

http://www.w3.org/2001/XMLSchema#string

P921

hyperprolactinemia

P932

3483691

http://www.w3.org/2001/XMLSchema#string